China pushes for lower cancer drug prices: Xinhua

SHANGHAI (Reuters) – China’s new medical insurance regulator will begin negotiations with domestic and overseas pharmaceutical companies to lower prices of cancer drugs in a bid to cut the financial burden on patients, state news agency Xinhua said on Saturday.

The State Medical Insurance Administration said it was preparing to include more cancer drugs on its list of medicines eligible for reimbursement, and said 10 foreign and eight domestic pharmaceutical companies had expressed a willingness to work with the authority.

China’s cancer rates have been soaring, driven by growing…

Read More Here

Be the first to comment on "China pushes for lower cancer drug prices: Xinhua"

Leave a comment

Your email address will not be published.